Benefits of AstraZeneca jab 'arguably' outweigh risks - Prof Paul Moynagh || News n Trick


Benefits of AstraZeneca jab 'arguably' outweigh risks - Prof Paul Moynagh
The European Medicines Agency (EMA) will today announce their decision on the AstraZeneca COVID-19 vaccine following a suspension on at least 11 EU ...
Newstalk
March 18, 2021 at 09:00PM
via YouTube https://www.youtube.com/watch?v=Ga5DAR_4LXM